Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation. (Q36057034)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

interferon alfa

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Jonathan Shepherd

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Håkan F T Brodin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Carolyn Backer Cave

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Norman R Waugh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alison Price

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

John Gabbay

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

International Journal of Technology Assessment in Health Care

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

47-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

21 January 2018

Interferon for interferon naive patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of viral levels during therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050063

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0266462305050063

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15736514%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36057034&oldid=1953968006"